Chief Operating Officer
Chief Operating Officer at GYRE THERAPEUTICS, INC., filing insider transactions between 2026-05-14 and 2026-06-18.
| SEC ↗ |
| 2026-06-10 | GYRE | Sale | 5,000 | $6.24 | $31K | SEC ↗ |
| 2026-06-09 | GYRE | Sale | 14.5K | $6.14 | $89K | SEC ↗ |
| 2026-06-09 | GYRE | Sale | 3,000 | $6.15 | $18K | SEC ↗ |
| 2026-06-05 | GYRE | Sale | 15.4K | $6.40 | $99K | SEC ↗ |
| 2026-06-04 | GYRE | Sale | 19.6K | $6.13 | $120K | SEC ↗ |
| 2026-05-26 | GYRE | Sale | 4,000 | $6.10 | $24K | SEC ↗ |
| 2026-05-22 | GYRE | Sale | 3,500 | $6.08 | $21K | SEC ↗ |
| 2026-05-21 | GYRE | Sale | 12.8K | $6.15 | $79K | SEC ↗ |
| 2026-05-20 | GYRE | Sale | 9,400 | $6.15 | $58K | SEC ↗ |
| 2026-05-19 | GYRE | Sale | 9,120 | $6.37 | $58K | SEC ↗ |
| 2026-05-18 | GYRE | Sale | 200 | $6.62 | $1K | SEC ↗ |
| 2026-05-15 | GYRE | Sale | 13.1K | $6.65 | $87K | SEC ↗ |
| 2026-05-14 | GYRE | Sale | 15.6K | $6.91 | $108K | SEC ↗ |